Skip to content
HowShorted

Candel Therapeutics, Inc. short interest in 2026

In 2026, Candel Therapeutics, Inc.'s disclosed short interest ran from 16.98% of shares outstanding on 15 Jan 2026 to 16.13% on 15 Sep 2026, a change of -0.85 percentage points. The year's high was 23.65% on 27 Feb 2026 and its low 16.03% on 31 Aug 2026, averaging 18.70% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.91 days on 13 Feb 2026. Full history: Candel Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Candel Therapeutics, Inc. in 2026

2026 in figures

Start of year
16.98% (15 Jan 2026)
End of year
16.13% (15 Sep 2026)
Change
-0.85 pp
High
23.65% (27 Feb 2026)
Low
16.03% (31 Aug 2026)
Average
18.70%
Highest days to cover
15.91 (13 Feb 2026)
SEC filings marked
7

Every report in 2026

Candel Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202616.98%12.97
30 Jan 202617.04%12.59
13 Feb 202616.93%15.91
27 Feb 202623.65%6.76results (8-K)
13 Mar 202619.36%11.1210-K filed, results (8-K)
31 Mar 202620.23%11.71
15 Apr 202620.57%15.51
30 Apr 202620.04%6.41
15 May 202619.69%5.5410-Q filed, results (8-K)
29 May 202619.34%7.64
15 Jun 202618.59%7.58
30 Jun 202622.03%5.98
15 Jul 202617.70%9.01
31 Jul 202617.28%10.41
14 Aug 202616.29%10.5610-Q filed, results (8-K)
31 Aug 202616.03%9.19
15 Sep 202616.13%10.28

See also: Candel Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.